DOW:NYSEDow Inc. Analysis
Data as of 2026-03-11 - not real-time
$33.89
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Dow Inc. is trading well above its 20‑day, 50‑day and 200‑day moving averages (price $33.89 vs SMA20 $31.93, SMA50 $29.14, SMA200 $25.84) and the MACD line sits above its signal, indicating a short‑term bullish momentum. The RSI at 64 reinforces this upside bias while the stock remains comfortably above the identified support at $29.20, though the resistance near $35.75 looms. However, the fundamentals are fragile: revenue is down 9%, margins are negative, trailing EPS is –$3.70 and free cash flow is negative, while debt ($19.6 B) dwarfs cash ($4.3 B) and the debt‑to‑equity ratio exceeds 100. The forward PE of roughly 49 and a high dividend yield of 5.1% mask a payout ratio that appears unsustainable given the earnings shortfall. Recent analyst upgrades to Overweight/Outperform reflect confidence in the technical setup and the newly declared dividend, but price targets averaging $29–$33 suggest a potential downside from current levels.
Overall, the stock presents a classic clash of strong short‑term price dynamics against a weak underlying financial profile, elevated volatility (≈49% 30‑day) and a high beta, making it a high‑risk play that may suit momentum traders but warrants caution for longer horizons.
Overall, the stock presents a classic clash of strong short‑term price dynamics against a weak underlying financial profile, elevated volatility (≈49% 30‑day) and a high beta, making it a high‑risk play that may suit momentum traders but warrants caution for longer horizons.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bullish technical indicators (price above SMAs, MACD bullish)
- Elevated volatility and high beta increasing price swing risk
- Unsustainable dividend given negative earnings and cash flow
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Continued earnings weakness and high leverage
- Analyst upgrades but price targets below current level
- Potential pressure on dividend if cash flow does not improve
Long Term
> 3 yearsCautious
Model confidence: 7/10
Key Factors
- Persistent negative margins and free cash flow deficit
- Debt load far exceeding cash reserves
- Forward valuation (PE ~49) suggesting limited upside
Key Metrics & Analysis
Financial Health
Revenue Growth-9.10%
Profit Margin-6.56%
P/E Ratio49.1
ROE-13.82%
ROA-0.07%
Debt/Equity111.87
P/B Ratio1.5
Op. Cash Flow$1.0B
Free Cash Flow$-784750016
Technical Analysis
TrendBullish
RSI64.6
Support$29.20
Resistance$35.75
MA 20$31.93
MA 50$29.14
MA 200$25.84
MACDBullish
VolumeIncreasing
Fear & Greed Index76.91
Valuation
Target Price$33.53
Upside/Downside-1.06%
GradeOvervalued
TypeValue
Dividend Yield5.10%
Risk Assessment
Beta1.49
Volatility48.87%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.